Press Release

For immediate release

John J. Alexander, Chairman

Twin Cities Angels Makes Two New Investments in Minnesota Start-up Companies
Minnesota-Based Angel Group Has Invested in 4 Minnesota Companies in its First Year

MINNEAPOLIS, (November 7, 2007) – Twin Cities Angels, LLC (“TCA”) today announced the closing of two investments in an early-stage Minnesota-based companies.  TCA was launched in mid- 2006 and has invested in 4 Minnesota-based early stage companies thus far. 

The most recent investments include: Bard’s Tale Beer, a micro-brewed beer offering superior taste to beer-lovers who are unable to drink conventional beers which contain glutein and Ovation Science, a watering device for gardeners which enriches water with high oxygen-content which has been shown to enhance the growth of houseplants, fruits and vegetables beyond what fertilizers alone can provide.

John Alexander, co-founder and Chairman of the TCAngels said, “Our members have been pleased with the quality of companies we have been reviewing over the past year and optimistic about the investments made. Even more importantly, we have shown that our Angel group business model is working both in the way our members can apply their individual talents to qualifying group investments and the value TCA is adding to the companies we review and to the companies in which we invest.

Details about the most recent investments follow:
Bard's Tale Beer Company has developed and is distributing a craft beer that is gluten-free that has been acclaimed by beer fans and gluten-intolerant individuals that cannot drink conventional beers containing malt. “The investment by the Twin Cities Angels will allow us to expand our distribution and implement our marketing and sales programs in the fast growing craft beer and gluten-free markets.”  Brian Kovalchuk, CEO of Bard'sTale Beer Company stated that, “Besides capital, the TCA provides us complementary business resources to draw upon as we execute our plan.  We are pleased to have the TCA as partners.”

Ovation Science Inc. has created a new product category around a novel technology that increased dissolved oxygen in water.  Focused on improving the natural ability of plant growth, the Company is the exclusive world wide licensee for a patented electrolysis technology and has launched products targeted at the $37 billion lawn & garden market.  Established in early 2006, Ovation Science located in Chanhassen MN has plans to launch additional products in both consumer and commercial markets.

“The caliber of people within Twin Cities Angels is fantastic.” said Paul Sjogren, President & CEO of Ovation.  “These are people who have experience with new ventures and, as we progressed through the due diligence phase,were willing to take us under their wing and help us through the process.”

Previously, TCAngels had invested in Placor and UnityWorks Media.

PlaCor, Inc., is a privately-held company that has developed a simple, easy-to-use, proprietary test for platelet reactivity called the PRT™.  Antiplatelet drugs, such as aspirin and Plavix®, reduce platelet reactivity and are prescribed to prevent heart attacks and strokes.  However, up to 50% of people may not respond to these drugs and are at an increased risk for an adverse event.  PlaCor’s PRT differs from other platelet reactivity tests in three important ways:  only a fingerstick blood sample is needed, total test time is less than 10 minutes and the test mimics how platelets are activated in the body.

UnityWorks Media uses proprietary technology to create inexpensive, high-quality streaming video advertisements on the internet with an initial market focus on automotive dealerships.  Streaming video ads are placed on the dealer’s own website, on 3rd party websites such as, and embedded into e-mail promotions issued by the dealer or one-on-one from a salesperson to a known prospect. These videos are hosted by UnityWorks Media.  UnityWorks has developed an extremely cost effective and efficient platform for businesses to send powerful, media rich content to any personal computer regardless of configuration and bandwidth.

About Twin Cities Angels:
Twin Cities Angels is a formal organization for entrepreneurially-minded member angel-investors.  TCA members have a mutual interest in having a high degree of personal involvement and interaction in angel investing.  All members are accredited investors with significant industry or functional expertise to contribute to the group.  TCA is principally interested in relatively early stage companies where the organization’s members can lead or participate in the formative stages of a successful business.  Based on their individual and collective expertise, TCA members are also committed to the organization’s mission of mentoring new companies by sharing their successful work experience and proven business judgment.  TCA’s investment and market focus is based on the members’ professional expertise, including but not limited to medical technology: devices, diagnostics, pharmaceuticals, biotech, veterinary medicine; and Information Technology: software, hardware, and IT services.

TCA seeks deal flow in the greater Twin Cities Area of Minneapolis/St. Paul, the state of Minnesota and within a reasonable distance of the Twin Cities in Wisconsin, Iowa, and the Dakotas. Members are educated in desirable investment skills: how to perform due diligence, deal flow creation, legal aspects of investing, term sheet key terms, the venture industry, technologies and other areas of specific interest to angel investors.  The membership-lead organization convenes regularly to meet with pre-screened companies regarding potential investments. 

More information about the Twin Cities Angels is available at